The search for human hematopoietic stem ceils has been hampered by the lack of appropriate assay systems. Demonstration of the ability of precursor cell candidates to give rise to T cells is of significant difficulty since dissociated in vitro cultured thymus stroma cells lose their ability to sustain thymocyte maturation. To define further the differentiative capacities of the rare human fetal liver and bone marrow cells that express the CD34 surface antigen and exhibit in vitro myeloid and pre-B cell activities, we have microinjected them into HLA-mismatched fetal thymus fragments, partially depleted of hematopoietic cells by low temperature culture. In vitro colonized thymuses have then been allowed to develop upon engraftment into immunodeficient SCID mice. Using this modification of the SCID-hu system, we show that low numbers of fetal CD34 + progenitor cells can repopulate the lymphoid compartment in the human thymus.
T
he production of hematopoietic cells in blood-forming organs requires interactions between progenitor cells and stromal elements that can be, in some instances, experimentally reproduced in vitro. Bone marrow cells, cultured in a two-dimensional arrangement, retain their ability to support myelopoiesis and B lymphocyte production, yielding convenient in vitro stem cell assays in both murine (see reference 1 for a review) and human (2; Bantu, C., and A. Tsukamoto, manuscript submitted for publication) models. In contrast, the maintenance of the three-dimensional structure of thymic reticulum appears to be a prerequisite for driving the full differentiation of stem cells into mature T lymphocytes. In the mouse, experimental T cell differentiation can be achieved in a quantitative manner by transfer of precursor cell candidates into irradiated hosts, either systemically (3) or by direct intrathymic injection (4, 5) . Similar physiologic assays of putative T cell precursors in man are, of course, impossible. The SCID-hu mouse, a chimera obtained by transplantation of human hematolymphoid tissue into a congenitally immunodeficient host, may provide an in vivo culture system for dissecting the human T ceil differentiation process (6) . In this study, we have first colonized lymphocyte-depleted human thymus fragments in vitro by HLA-mismatched putative precursor cells, then transplanted them into C.B.17 scid/scid (SCID) mice to facilitate expansion and differentiation of the donor cell population. The candidate hematopoietic precursor calls we have first analyzed in this experimental system express the CD34 surface antigen and represent "~1-4% of bone marrow and fetal liver cells. CD34 + cells can be shown to include colony-forming units endowed with myeloid (7) (8) (9) and pre-B cell activity (Baum, C., and A. Tsukamoto, manuscript submitted for publication); they also give rise to colonies of blast cells on bone marrow stroma capable of self renewal and multilineage commitment (10) . These observations suggest that the CD34 + cell pool may include multipotential stem cells.
Materials and Methods
Hematopoietic Depletion and Reconstitution of the Human Fetal hymus. Individual lobules from 19-22-wk fetal thymuses obtained om elective abortions were placed on sterile nitrocellulose filter squares (1 cmx 1 cm) (Millipore Corp., Bedford, MA) supported by absorbent gelatin sponges (Gelfoam; UpJohn, Kalamazoo, MI), in 3.5-cm petri dishes containing 2 ml of RPMI, 10% heatinactivated FCS, and penicillin/streptomycin, for 7 d at 25~ in a 5% CO2 atmosphere. An oil-filled syringe (Hamilton Co., Keno, NV) with a screw-operated plunger was used to inject, through glass micropipettes, suspensions (0.5-1 #1) of HLAmismatched CD34 + or CD34-cells into low temperature-cultured thymus fragments. In vitro colonized thymus fragments were inserted under the kidney capsule of Nembutal-anesthetized CB17 scid/scid mice bred in our own facility.
Sorting of Hematopoietic Precursor Cells from Human Fetal Blood-,forming Organs. Human fetal marrow cell suspensions were prepared from long bones of 15-20-wk-fetuses. The bones were split lengthwise, then placed in a 1-mg/ml solution of collagenase/dispase in RPMI 1640 for 30 rain at 37~ after which time the medullary cavity was flushed with medium (RPMI 1640 with Pen/Strep, 2-ME, and 10% FCS) to remove hematopoietic cells. Red blood lmmunohistochemical Analysis of CD34 + Cell.reconstituted Human Fetal Thymus Grafts. 6-/zm cryostat sections of frozen grafts were air-dried and fixed with acetone. Rehydrated sections were incubated successively with mouse monoclonal anti-human class I antibody, biotinylated-horse anti-mouse Ig antibody (Vector Labs., Inc., Burlingame, CA), and avidin-alkaline phosphatase at room temperature. For development, a mixture of Fast Blue BB salt (2.5 g in 50/zl dimethylformamide) and naphtol AS phosphate (2.5 mg in 50 #1 dimethylformamide) was used, in 2.5 ml of 0.05 M propanediol buffer, pH 9.75, containing 60/zl of 10 mM levamisole to block endogenous enzyme activity. Sections were then postfixed with 20% formalin for 5 rain, washed in distilled water, counterstained with hematoxylin, and mounted in gelatin-glycerol. 
lhsults and Discussion
Reducing the size of the thymus hematopoietic cell compartment is a prerequisite to experimental reconstitution and can be achieved by low temperature in vitro organ culture (11) . Human thymus tissue cultured at 25~ appeared as a loose epithelial network, showing large lymphocyte-free areas (not shown), as previously described in the mouse model (11) . HLA-mismatched CD34 + or CD34-cell suspensions sorted from fresh human fetal liver or bone marrow were delivered by microinjection to the depleted thymus pieces. After engraftment under the kidney capsule of SCID mice, low temperature-cultured, in vitro colonized thymus fragments were vascularized and grew. At intervals, grafts were harvested, reduced into cell suspensions, and analyzed for chimerism in the T cell compartment. Using a two-color immunofluorescence assay class I HLA antigens served as markers for donor vs. host-derived lymphocytes. The initial phase of thymus lymphoid repopulation from injected donor cells was difticult to trace given the fact that nonmature and immature cortical thymocytes express very low quantities of class I antigens.
Chimerism could be evidenced when the progeny of transferred cells was differentiated far enough to express detectable amounts of class I molecules, which occurred 3-4 wk after the engraftment of thymus colonized with 104 CD34 + cells (Fig. 1 A) . From this time onwards, the donor-derived population was observed to expand and mature, with larger numbers of thymocytes in the graft expressing higher amounts of the donor class I antigens. After 6 wk, the donor-derived thymocyte population in the graft was similar to that of a fresh normal thymus, with respect to its range of CL I antigen expression (Fig. 1, B and D) . Eventually, the progeny of the transferred CD34 § cells appeared as populations of mature-type T lymphocytes, expressing high levels of class I antigens (Figs. 1 C and 2, A-C) . These cells were analyzed by three-color immunofluorescence and found to include, in the expected proportions, donor-derived elements that were either CD4 + or CD8 + (not shown). In contrast, no T cell repopulation was ever observed after transfer of fetal liver or bone marrow CD34-counterpart cells, which were analyzed in the same conditions in all experiments. The successful To visualize the tissue distribution of the cells generated by the microinjected precursor cell population, sections from thymus grafts fully reconstituted with 103 CD34 + cells were stained with mAbs specific for either host or donor class I HLA antigens. Host class I molecules were restricted to epithelial cells in the cortex and at the corticomedullary junction, and of cells with a dendritic morphology in the medulla where, by contrast, no stained lymphocytes were present (Fig.  3) . The donor-specific anti-class I reagent stained almost exclusively packed lymphocytes in the medullary region. Whether cortical thymocytes were all donor derived or included resurgent host cells could not be determined in the present experimental system. These results show that at least a fraction of the CD34 + cell population present in the fetal liver and bone marrow has the ability to differentiate into thymic lymphocytes when experimentally introduced into the thymic microenvironment. Human CD34 § cells are phenotypically heterogenous and can be subdivided into several subsets coexpressing, among others, the myeloid-specific CD33, B cell-specific CD19 and CD10, and T cell-restricted CD7 lineage markers. Interest-ingly, human in vitro colony-forming cells can be distinguished from their precursors since only the former express CD33, whereas all of them are CD34 + (12) . CD7 is believed to be expressed by extrathymic pre-T cells (13, 14) . The abovedescribed thymic reconstitution assay should allow the definition of the subsets of human bone marrow cells that can give rise to thymic colonization and T cell differentiation, using techniques that defined at least two subsets of mouse bone marrow cells with this potential (15) .
Due to the unavoidable variability of human material, differences are noted in the kinetics and extent of the T cell repopulation observed after in vitro intrathymic transfer of precursor cells. Also, in some cases, precursor cells sorted from one given donor were unable to reconstitute a particular thymus, at any number of transferred ceils, suggesting that allogeneic reconstitution may be dependent upon yet unknown compatibility requirements. These constraints may be similar to those genetically defined factors enforcing host resistance to donor hematolymphoid transplants, even in irradiated hosts (16) . However, despite these limitations, >40 successful T cell repopulations have been observed after CD34 + cell transfer.
In animal models, experimental chimeras have been instrumental at elucidating the complex cell interactions involved in the ontogeny of the thymus (17) . Defining the ability of potential progenitors to differentiate into T lymphocytes is an important step towards the characterization and purification of human hematopoietic stem ceils, as well as in the study of positive selection (MHC restriction) and negative selection (self-tolerance) of developing human thymocytes from genotypicaily defined precursors in contact with genotypically defined thymic stroma. Also, this system may allow studies towards the elucidation of potential human bone marrow targets of pathogenic human lymphotropic viruses such as HIV, HTLV, and EBV.
